|
HNRPLL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.960030E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.174140E-04 |
| Normal-vs-Stage2 |
1.247880E-02 |
| Normal-vs-Stage3 |
1.844020E-01 |
| Normal-vs-Stage4 |
1.738400E-01 |
| Stage1-vs-Stage2 |
6.297800E-01 |
| Stage1-vs-Stage3 |
1.743230E-01 |
| Stage1-vs-Stage4 |
7.320600E-01 |
| Stage2-vs-Stage3 |
4.981800E-01 |
| Stage2-vs-Stage4 |
9.968000E-01 |
| Stage3-vs-Stage4 |
6.552800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.401370E-04 |
| Normal-vs-AfricanAmerican |
2.697600E-03 |
| Normal-vs-Asian |
3.728200E-01 |
| Caucasian-vs-AfricanAmerican |
8.480800E-01 |
| Caucasian-vs-Asian |
5.093000E-01 |
| AfricanAmerican-vs-Asian |
5.114600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.3333999999986E-05 |
| Normal-vs-Female |
3.587000E-01 |
| Male-vs-Female |
8.183800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.377390E-03 |
| Normal-vs-Extreme_Weight |
4.18260000000226E-05 |
| Normal-vs-Obese |
7.229900E-02 |
| Normal-vs-Extreme_Obese |
7.158700E-04 |
| Normal_Weight-vs-Extreme_Weight |
6.578600E-01 |
| Normal_Weight-vs-Obese |
1.409980E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.810400E-01 |
| Extreme_Weight-vs-Obese |
2.836100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.293800E-01 |
| Obese-vs-Extreme_Obese |
9.579600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.718200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.058050E-02 |
| Normal-vs-Age(61-80Yrs) |
1.69159999999779E-05 |
| Normal-vs-Age(81-100Yrs) |
2.773500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.540400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.385800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.440420E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.379600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.703900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.639800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.640400E-04 |
| Normal-VS-Type2 PRCC |
8.08830000000871E-05 |
| Normal-VS-KIRP CIMP |
2.204200E-01 |
| Normal-VS-Unclassified PRCC |
7.219600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.807800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.334000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.840380E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.466140E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.674400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.445890E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.66020000045431E-07 |
| Normal-vs-N1 |
9.682400E-01 |
| Normal-vs-N2 |
3.515500E-02 |
| N0-vs-N1 |
6.296300E-03 |
| N0-vs-N2 |
9.090000E-01 |
| N1-vs-N2 |
2.464600E-01 |
|
|
